Announcements Trials
Browse Landscape

Status

Completed 3Terminated 2Unknown 1Recruiting 1

Sponsor Class

INDUSTRY 4OTHER 3

Study Type

Interventional 61Observational 7

Sponsor

Cancer Type

Gastrointestinal 7Genitourinary 2Thoracic 1

Conditions

Carcinoma, Hepatocellular 20Carcinoma, Renal Cell 16Liver Neoplasms 7Leukemia, Myeloid, Acute 3Thyroid Neoplasms 2Financial Stress 2Carcinoma 2Patient Preference 1Neuroendocrine Tumors 1Neoplastic Cells, Circulating 1Kidney Neoplasms 1Colorectal Neoplasms 1Childhood Acute Myeloid Leukemia/Other Myeloid Malignancies 1Carcinoma, Non-Small-Cell Lung 1COVID-19 1Adenoma, Islet Cell 1

Interventions

Hepatectomy 10Blood Specimen Collection 9Sorafenib 7Polymerase Chain Reaction 4Biopsy 4regorafenib 3Mass Spectrometry 3Liver Transplantation 3Immunohistochemistry 3Chemoembolization, Therapeutic 3Walking Speed 2Surveys and Questionnaires 2Psychiatric Rehabilitation 2Magnetic Resonance Imaging 2Gene Expression Profiling 2Bevacizumab 2trastuzumab deruxtecan 1taxane 1spartalizumab 1sintilimab 1lenvatinib 1gadolinium ethoxybenzyl DTPA 1donafenib 1carmofur 1camrelizumab 1cabozantinib 1atezolizumab 1apatinib 1anlotinib 1Yttrium-90 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

7 trials
RecentStart dateEnrollment
Observational × Liver Neoplasms × Sorafenib × Clear all
NCT05713994 2025-03-25

CCGLC-001

Tongji Hospital

Recruiting
300 enrolled
Gastrointestinal

Carcinoma, Hepatocellular, Liver Neoplasms

NCT03644511 2020-08-21

SORAGO-HCC

Bayer

Terminated
3 enrolled
Gastrointestinal

Carcinoma, Hepatocellular, Liver Neoplasms

NCT01839630 2017-12-20

SUCCESS

Bayer

Completed
302 enrolled
Gastrointestinal

Carcinoma, Hepatocellular, Liver Neoplasms

NCT02616692 2017-09-27

HCC Patient Preferences in Japan

Bayer

Completed
120 enrolled
Gastrointestinal

Liver Neoplasms, Patient Preference

NCT01539681 2016-02-18

STELLA

Bayer

Completed
234 enrolled
Gastrointestinal

Carcinoma, Hepatocellular, Liver Neoplasms

NCT01507740 2015-04-29

Profile of Soluble and Cellular Biomarkers and of Functional Imaging During Antiangiogenic Therapies in Cancer Patients

Medical University Innsbruck

Terminated
60 enrolled
GastrointestinalGenitourinaryThoracic

Carcinoma, Non-Small-Cell Lung, Carcinoma, Renal Cell, Liver Neoplasms, Colorectal Neoplasms

NCT01230697 2010-10-29

SORHORM

University of Turin, Italy

Unknown
60 enrolled
GastrointestinalGenitourinary

Carcinoma, Hepatocellular, Kidney Neoplasms, Liver Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡